Overview

Study To Understand Efficacy And Safety Of Investigational Agent (PF-04937319) Compared To Approved Agent (Glimepiride) In Patients With Diabetes On Metformin

Status:
Completed

Trial end date:
2013-01-01

Target enrollment:

Participant gender:

Summary

This is a study to understand efficacy and safety of investigational agent (PF-04937319) compared to approved agent (glimepiride) in patients with diabetes on metformin

Phase:

Phase 2

Details

Lead Sponsor:

Pfizer

Treatments:

Glimepiride
Metformin